|Articles|November 13, 2009

Diabetes & Obesity Podcasts: Obesity Drugs and Co-Morbidities

Diabetes & Obesity Series


Obesity Drugs and Co-Morbidities

Subscribe to RSS feed of this series



Dr. Richard Gregg
Chief Scientific Officer
Vitae Pharmaceuticals



Dr. Gregg offers insight into the development of obesity drugs, and how co-morbidities factor into development, as well as how it impacts sites and CROs in Phase I through III trials.

Others in the Series



Diabetes Resources

Associations and Societies


Clinical Trials

Obesity Resources

Articles, Multimedia


Associations and Societies

Clinical Trials

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.